Meeting Archive
2015 Calendar
JOINT GLI/GDI PARTNERS FORUM FOR STRENGTHENING AND ALIGNING TB DIAGNOSIS AND TREATMENT
Organized by the World Health Organization (WHO) Global TB Programme WHO Executive Board Room, Geneva,
27-30 April 2015
2014 Calendar
Meeting on high-priority target product profiles for new TB diagnostics
Geneva, Switzerland
28 - 29 April 2014
6th GLI Partners' Meeting
Executive Board Meeting Room, WHO, Geneva
30th April - 2nd May 2014
- Agenda and presentations
- Xpert Implementers Global Forum meeting report
- List of Participants
- Nomination of the NRL Copenhagen as WHO/GLI TB Supranational Reference Laboratory
- Nomination of the NITRD New Delhi as National Centre of Excellence and part of WHO/GLI TB Supranational Reference Laboratory network
- Nomination of Aga Khan University in Karachi as WHO/GLI TB Supranational Reference Laboratory
- 3 nominated members of the SRL network
2013 Calendar
5th Annual GLI Partners’ Meeting
Les Pensières, Veyrie-du-Lac, France
15-18 April 2013
- Announcement
- Agenda and Presentations
- List of participants
- Speech of Mario Raviglione
- Nomination of the NTRL Uganda as WHO/GLI TB Supranational Reference Laboratory
- Group photo
2012 Calendar
1st International Conference of the African Society for Laboratory Medicine (ASLM)
Accurate Laboratory Diagnostics - A Pillar of Quality Healthcare
Cape Town International Convention Centre, South Africa
4-7 December 2012
For more information, click here
1st International Forum on Diagnostics (IFDIAG)
Les Pensières Conference Centre, Annecy, French Alps
2-9 September 2012
For more information, click on http://www.fondation-merieux.org/
4th Annual GLI Meeting/Consultation of the SRL network/Early implementers meeting on Xpert MTB/RIF roll out
Les Pensières, Veyrier-du-Lac, France
17-19 April 2012
Agenda and presentations
List of Participants
WHO Expert Group Meeting (WHO-EGM): Policy guidance on the use of Loop-mediated Isothermal Amplification (LAMP) assay for detection of tuberculosis
WHO Geneva, Switzerland
20 April 2012
Expert Group Meeting report
WHO Expert Group Meeting (WHO-EGM): Policy Guidance on anti-tuberculosis drug susceptibility testing
WHO Geneva, Switzerland
19-20 March 2012
WHO Expert Group Meeting (WHO-EGM): Policy Guidance on Hain MTBDRsl second-line drug molecular line probe assays
WHO Geneva, Switzerland
21 March 2012
Expert Group Meeting report
2011 Calendar
Meeting on Lab Accreditation
Geneva, 6 - 7 July
Agenda
Day 1
- AFRO PRESENTATION TB GLI MEETING ON ACCREDIT_AA [.pdf]
- Cognat GLI July 2011_Cognat [.pdf]
- Datema 110706_Geneva_v0.3 [.pdf]
- Fine Glen Accred overview ppt 06 July 2011 [.pdf]
- Klatser 20110706 GLI Geneva Paul Klatser [.pdf]
- Peart WHOPres1 (Bambi) [.pdf]
- Ridderhof GLI accreditation July2013 Ridderhof [.pdf]
- Shinnick_Comparison_2011_final [.pdf]
- Twell GLI Consult 6_7July2011JT [.pdf]
Day 2
- Biosafety Jeju 2010 [.pdf]
- Engelberts 20110706 NTRL Uganda GLI Geneva [.pdf]
- Oskam 110707 GLI meeting presentation [.pdf]
Review of Global Laboratory Initiative (GLI) and World Health Organization (WHO) tools and guidance for laboratory strengthening
WHO Geneva, Switzerland
22-24 August 2011
2010 Calendar
Use of commercial serological tests for the diagnosis of TB
Date and time: 22 July 2010, 09:00 - 1600
Venue: Salle B, WHO-HQ Main Building, Geneva, Switzerland
Agenda
Meeting report
Policy statement on use of commercial serological tests for the diagnosis of TB
Use of Interferon - Gamma Release Assays (IGRAs) in TB control in low and middle-income settings
Date and time: 20-21 July 2010, 09:00 - 18:00
Venue: WHO-HQ, Geneva, Switzerland
Agenda
Meeting report
Policy statement on use of Interferon - Gamma Release Assays (IGRAs) in TB control in low and middle-income settings
GLOBAL CONSULTATION ON THE IMPLEMENTATION AND SCALE-UP OF THE "GeneXpert MTB/RIF System" FOR RAPID DIAGNOSIS OF TB AND MDR-TB
Date and time: 30 November -02 December 2010, 09:00 - 18:00
Venue: Centre International de Conférences de Genève (CICG)
17, Rue Varembé, Geneva, Switzerland
Agenda
Presentations
Day 1
session 1
- Meeting scope and objectives K Weyer [.pdf]
- New frontiers changing diagnostic paradigms G Roscigno [.pdf]
- Responding to change Rapid policy development by WHO M Raviglione K Weyer [.pdf]
session 2
- Xpert MTB RIF - development and analytical performance M Perkins [.pdf]
- Xpert MTB RIF - evidence and operational considerations C Boehme [.pdf]
- Xpert MTB RIF - update on price negotiations and market dynamics G Roscigno [.pdf]
session 3
- An ethical dillemma - diagnosis without treatment A Reis [.pdf]
- From diagnosis to treatment and care - the missing links P Nunn [.pdf]
- Xpert MTB RIF - opportunity to enhance private sector engagement M Uplekar [.pdf]
- Xpert MTB RIF - scenarios for cost effectiveness A Vassall [.pdf]
- Xpert MTB RIF in the Global plan 2011-2015 - what it will cost K Floyd [.pdf]
session 4
- Civil society perspective F Varaine [.pdf]
- Civil society perspective J Syed [.pdf]
- Pateint Perspectives on GeneXpert L Chesire N Otwoma [.pdf]
- Use of Xpert MTB RIF in the private sector - Pakistan A Khan [.pdf]
session 5
- Global Consultation Algorithm Xpert DOTS Expansion [.pdf]
- Global Consultation Algorithm Xpert TBHIV [.pdf]
- Global Consultation Xpert Algorithm MDR-TB [.pdf]
Day 2
- Discussion on diagnostic algorithm with Xpert DOTS Expansion [.pdf]
- Discussion on diagnostic algorithm with Xpert MDR-TB [.pdf]
- Discussion on diagnostic algorithm with Xpert TB HIV [.pdf]
Day 3
- Country plan for scaling up Xpert MTB-RIF G Coetzee [.pdf]
- Final diagnostic algorithm with Xpert MDR D Falzon [.pdf]
- Final diagnostic algorithm with Xpert DOTS Expansion S Sahu [.pdf]
- Final diagnostic algorithm with XpertTB HIV D Sculier [.pdf]
- Global Roadmap for scaling up Xpert MTB-RIF K Weyer [.pdf]
- Increasing access to vulnerable groups through TB REACH L Ditiu [.pdf]
- Learning by doing through EXPAND-TB E Adam [.pdf]
- Mobilising country capacity through TB CARE A Piatek [.pdf]
- Targeting HIV settings through PEPFAR B Coggin [.pdf]
- Xpert_TBHIV_ambulatory_02 12 10_v1 [.pdf]
- Xpert_TBHIV_seriously ill_02 12 01_v1doc [.pdf]
Creating Partnerships for Innovation in Tuberculosis Diagnostics and Laboratory Services:
3rd Global Laboratory Initiative (GLI) Meeting Jointly organised by World Health Organization & Fondation Mérieux
Date and time: 04 -05 October 2010, 09:00 - 18:00
Venue: Les Pensières, Veyrier-du-Lac, France
Agenda
Presentations
Lundi
- Expand TB for 3rd GLI meeting [.pdf]
- Fuad Expand TB for 3rd GLI meeting [.pdf]
- GLI 2010 WEYER [.pdf]
- GLI annecy 2010 [.pdf]
- GLI Priorties Annecy 04OCT10 [.pdf]
- Integration slidesGLI Annecy Oct 2010 [.pdf]
- Mundy,C-GLI Presentation - Lab Tools Package 4 Oct 10 [.pdf]
- TB DxTics Pipeline GLI Annecy 04OCT10 [.pdf]
- TB REACH GLI ppt Oct 10 [.pdf]
Mardi
- 101005 DTLab and GLI [.pdf]
- 20101004 GLI PaulKlatser [.pdf]
- GLI accreditation smear networks [.pdf]
- Hakiruwizera - GLI 1- Annecy Oct 2010.JT [.pdf]
- IOM Laboratory services for 3rd GLI meeting Oct'10 [.pdf]
- Lab Information - LIPHE - Oct 5 2010 -- final [.pdf]
- Pawan Ventilation workstationOct 05 [.pdf]
- SRLN_Annecy_2010 [.pdf]
- UnionLab2010 [.pdf]
- USAID_GLI_Oct_2010 [.pdf]
GLOBAL CONSULTATION OF THE WHO-GLI TB SUPRANATIONAL REFERENCE LABORATORY NETWORK
Date and time: 14-15 April 2010, 09:00 - 18:00
Venue: Main Building room A, WHO Geneva, Switzerland
Agenda
Meeting Report
TOR
Eligibility Criteria
Presentations
- 00 - Current WHO Policy Update [.pdf]
- 01 - Current draft WHO-CDC Biosafety recommendations [.pdf]
- 02 - GLaDMap Global Laboratory Database [.pdf]
- 03 - Overview of SRLN efforts [.pdf]
- 04 - WHO AFRO Regional Perspective [.pdf]
- 05 - WHO EMRO Regional Perspective [.pdf]
- 06 - WHO SEARO Regional Perspective [.pdf]
- 07 - WHO WPRO Regional Perspective [.pdf]
- 08 - WHO PAHO Regional Perspective [.pdf]
- 09 - GLI Roadmap [.pdf]
- 10 - Optimizing the SRLN in Africa [.pdf]
- 11 - Eligibility criteria [.pdf]
- 12 - SRL accreditation - What is needed [.pdf]
- 13 - Summary Day 1 [.pdf]
- 14 - Creation of formal links with SRL and NRL [.pdf]
- 15 - ExpandTB Project [.pdf]
- 16 - SRL TA for DRS [.pdf]
- 17 - ERLN for Tuberculosis European [.pdf]
- 18 - Donor perspectives on SRLN funding (Governmental) [.pdf]
- 19 - Donor perspective Eli Lilly [.pdf]
- 20 - Conclusion and Next steps [.pdf]
- 21 - Proposed TORs for the SRLN [.pdf]
GLI Consultants Workshop
To support TB laboratory strengthening efforts in Global Fund round 10 proposals preparation
Dates: 12th-16th July 2010
Venue: Room HTM65 D Building WHO Geneva, Switzerland
Background and Objectives
Agenda
2009 Calendar
2nd Annual GLI Meeting jointly organized by WHO and Fondation Mérieux:
Presentations
- Microsoft PowerPoint - Armand VAN DEUN [.pdf]
- Microsoft PowerPoint - Gavin MACGREGOR SKINNER [.pdf]
- Microsoft PowerPoint - Jessica MINION [.pdf]
- Microsoft PowerPoint - JF de LAVISON [.pdf]
- Microsoft PowerPoint - John NKENGASONG 2 [.pdf]
- Microsoft PowerPoint - John NKENGASONG [.pdf]
- Microsoft PowerPoint - John RIDDERHOF [.pdf]
- Microsoft PowerPoint - Karen STEINGART [.pdf]
- Microsoft PowerPoint - Karin WEYER [.pdf]
- Microsoft PowerPoint - Keith KLUGMAN [.pdf]
- Microsoft PowerPoint - Kitty LAMBREGTS [.pdf]
- Microsoft PowerPoint - Linda OSKAM [.pdf]
- Microsoft PowerPoint - Lucia BARRERA [.pdf]
- Microsoft PowerPoint - Maarten VAN CLEEFF [.pdf]
- Microsoft PowerPoint - Mario RAVIGLIONE [.pdf]
- Microsoft PowerPoint - Mark PERKINS [.pdf]
- Microsoft PowerPoint - Paul KLASTER [.pdf]
- Microsoft PowerPoint - Paul NUNN [.pdf]
- Microsoft PowerPoint - Thomas SHINNICK [.pdf]
NON-COMMERCIAL CULTURE METHODS AND MYCOBACTERIOPHAGE-BASED ASSAYS FOR RAPID SCREENING OF PATIENTS AT RISK OF DRUG-RESISTANT TUBERCULOSIS
Date and time: 08 - 09 September 2009, 09:00 - 18:00
Venue: Crowne Plaza Hotel, Geneva, Switzerland
Agenda
Meeting Report
Policy statement on non-commercial culture and drug-susceptibility testing methods for screening patients at risk for MDR-TB
APPROACHES TO IMPROVE SPUTUM SMEAR MICROSCOPY FOR TUBERCULOSIS DIAGNOSIS
Date and time: 07 September 2009, 08:30 - 18:00
Venue: Crowne Plaza Hotel, Geneva, Switzerland
Agenda
Meeting Report
Policy statement on same-day diagnosis of tuberculosis by microscopy
Policy statement on Fluorescent light-emitting diode (LED) microscopy for diagnosis of tuberculosis
WHO Expert Group Meeting (WHO-EGM): Guidance on Biosafety related to TB laboratory diagnostic procedures
WHO Geneva, Switzerland
08-09 April 2009